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HIV pre-exposure prophylaxis (PrEP) has likely contributed to large decreases in HIV inci-
dence among men who have sex with men (MSM) in several major cities. Berlin has seen a
smaller decline, and affordable PrEP has been accessible through formal channels in Ger-
many only since autumn 2017. We aimed to investigate knowledge and use of PrEP among
MSM in Berlin, and factors predictive of a desire to use PrEP and history of PrEP use.
Methods
Multicentre, paper-based, self-administered survey of adult MSM whose HIV status was
negative or unknown at time of participation. Data were collected from 1 October 2017 to 2
April 2018.
Results
473 of 875 questionnaires were returned (response rate 54.1%; mean age 37.4 years,
range 18–79). 90.0% of participants were aware of PrEP and, of these, 48.2% felt well
informed about it. Among the 17.2% of participants reporting PrEP use, 59.3% indicated
obtaining some or all of it from informal sources. 23.7% of those with no history of PrEP use
reported having condomless anal intercourse (CAI) with two or more partners over the past
six months. Worries about side effects, cost, not having a doctor who prescribes it, and a
lack of information were the most frequently reported barriers to PrEP use. A desire to use
PrEP and history of PrEP use were associated in our multivariable model with having
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multiple CAI partners. A history of PrEP use was associated with having a university degree,
one or two parents born outside Germany, or friends living with HIV.
Conclusions
We found high awareness of PrEP among MSM in Berlin, but also a strong need for more
education on its pros, cons and proper use. The frequency of informal PrEP use was also
high, raising urgent individual and public health concerns. Policy makers need to consider
recent calls to improve access to PrEP and PrEP education through regular health services.
Introduction
HIV pre-exposure prophylaxis, or PrEP, is a biomedical form of HIV prevention that has dem-
onstrated high efficacy and safety in clinical trials [1–4] and cohort studies [5–15]. In 2017 the
Centers for Disease Control and Prevention (CDC) in the United States issued an updated
clinical practice guideline recommending PrEP for men who have sex with men (MSM) and
who report having had a bacterial sexually transmitted infection (STI), anal sex without con-
doms outside a monogamous relationship with an HIV-negative partner, or both within the
past six months [16]. The results of a modelling study from 2016 suggest that achieving 40%
coverage of indicated MSM would avert 33% of infections expected in the US over the next
decade [17]. Indeed, increased use of PrEP is thought to have already contributed to substan-
tial declines in HIV incidence among MSM in London [18], San Francisco [19] and New
South Wales, Australia [20].
To become an effective part of HIV prevention strategies, PrEP must be made accessible to
the populations at highest risk of HIV infection, such as MSM. However, while awareness of
PrEP among MSM is generally increasing [21–25], it varies widely across geographies [26,27],
as well as socioeconomic and ethnic groups [28,29]. Likewise, the willingness of MSM to use
PrEP is influenced by various factors, including cost, perceived level of protection against HIV
infection, adverse effects and socioeconomic status [30–32].
In Germany, the incidence of HIV among MSM has decreased since 2013, falling from
2500 new cases that year to an estimated 2100 in 2016 [33]. This decline has been attributed
primarily to the use of HIV treatment as a form of prevention [33]. Around 20% of new cases
of HIV among MSM in Germany in 2016 were diagnosed in immigrants, with central Europe,
western Europe and South America being the most frequent regions of origin [34]. The Ger-
man states with the highest HIV incidence were the city-states of Berlin and Hamburg, both of
which saw 10.1 new cases of HIV per 100,000 population compared to an incidence of 4.2 per
100,000 in Germany as a whole [34].
Berlin joined the Fast-Track Cities initiative of the Joint United Nations Programme on
HIV/AIDS (UNAIDS) in 2016 and, in doing so, committed to attain the 90-90-90 and zero
stigma and discrimination targets. In addition to its major goal of rapidly expanding the use of
HIV treatment as a highly effective form of prevention [35], the initiative recommends
improved and more widespread implementation of other preventive strategies, such as PrEP
[36]. The current Berlin state government is planning a model project to deliver free PrEP ser-
vices to a limited number of people who are not able to afford these themselves [37], satisfying
some of the demands of local HIV counselling centres and NGOs [38].
Despite these commitments and plans, very little information is available on what MSM in
Germany know about PrEP, the extent to which and how they use it, and the attitudes they
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have towards it. In particular, there is no information of this nature specifically for Berlin. The
aim of our study was therefore to survey MSM attending HIV specialist practices or HIV test-
ing and counselling centres on these topics and to identify barriers, enablers and other factors
associated with participants’ desire to use PrEP and any history of PrEP use. Data of this nature
from Berlin can provide a useful comparison to the situation in cities such as London or Paris,
where the implementation of PrEP is already well underway.
Materials and methods
Study design
We conducted a cross-sectional, multicentre survey of MSM attending HIV specialist practices
or HIV testing and counselling centres in Berlin using an anonymous, self-administered,
paper-based questionnaire. The study protocol was approved by the institutional ethics com-
mittee of Charite´–Universita¨tsmedizin Berlin (EA1/162/17, 28 September 2017). Participation
was voluntary and all participants gave verbal informed consent in English or German before
filling in the questionnaire. We did not provide any incentives to the centres or participants to
take part in the study.
Sampling methods and settings
MSM were eligible to take part in the survey if they were aged 18 years or older and had a self-
reported negative or unknown HIV serostatus at the time of participation. Data were collected
from 1 October 2017 to 2 April 2018. Because we aimed to recruit a heterogeneous sample of
MSM in Berlin, we collected data in various settings: HIV and STI testing and counselling cen-
tres for MSM and HIV specialist practices. The former are walk-in centres offering low-thresh-
old, anonymous counselling on legal and health issues, as well as testing for HIV and STIs.
They are not permitted to prescribe medication. We invited all of these centres in Berlin
(n = 4) to participate in our study. HIV specialist practices in Berlin are owned and staffed by
doctors, and visiting them usually requires an appointment. They provide a range of generalist
and sexual health care to LGBTI+ people whether or not they are living with HIV. We invited
a total of 11 such practices from seven different neighbourhoods across Berlin to participate in
our study. These were chosen purposively based on their geographic spread and our knowl-
edge that they had participated in other research related to HIV.
Counsellors invited eligible clients to participate in the survey if they were seeking STI or
HIV tests or counselling. Patients at the HIV specialist practices were selected by participating
doctors, who had been asked to include every eligible patient consecutively regardless of the
reason for the patient consultation. The questionnaire was prefaced with information about
PrEP and our survey.
Content and format of the questionnaire
We designed a two-page questionnaire consisting mostly of closed multiple-choice questions
with single or multiple answers allowed. The questions covered the following topics, all of
which focused on the perspective of the participating MSM:
• awareness of PrEP and sources of information about it;
• desire to use PrEP and history of PrEP use;
• barriers to PrEP use, including perceived risks;
• preferences for dosage regimen and route of administration;
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• anticipated impact of taking PrEP on the participants’ use of condoms; and
• attitudes towards pricing and reimbursement through public insurance.
In addition, we asked questions about participants’ sexual behaviour and HIV risk (date of
last HIV test, diagnosis of any STI in the past six months, role in anal sex, number of anal sex
partners in the past six months, number of anal sex partners without condoms in the past six
months). We also collected sociodemographic data (age, place of residence, education, finan-
cial situation and family origins). The last of these variables was chosen to capture information
on whether participants had a family or personal history of immigration to Germany.
Additionally, the questionnaire contained an open-ended question focusing on the motiva-
tion behind participants’ use of, or desire to use, PrEP. These data will be reported elsewhere.
The questionnaire was available in German and English, and the full versions are available as
supporting information (S1 and S2 Files).
Sample size and statistical methods
No formal sample size calculations were performed. Based on considerations of feasibility, we
aimed to collect data from 400 to 600 participants. We used descriptive statistics to summarise
sample characteristics and Pearson’s chi-squared test to measure the association among pre-
selected categorical variables. For the latter analyses, we applied a Bonferroni-adjustment to
account for multiple testing (alpha level at 0.005). Additionally, we used multivariable logistic
regression to identify predictors of having a desire to use PrEP or a history of PrEP use. Odds
ratios and their respective 95% confidence intervals were used to quantify the effects. To select
variables for our multivariable model, we compiled the following initial working set of poten-
tial predictors in which we had a priori interest based on background knowledge: age, financial
situation, education, family origins, sexual risk behavior, self-perceived risk, having peers liv-
ing with HIV, and perceived barriers and risks of PrEP. For pragmatic reasons of reporting
and traceability, we subsequently screened these using simple (i.e., univariable) logistic regres-
sion and included in the multivariable model those variables that were associated with the
respective dependent variable at a p-value cut-off point of 0.075 following the approach
described by Bursac et al. [39]. We later conducted a sensitivity analysis with all variables of a
priori interest to ensure that important adjustment variables had not been overlooked. Missing
cases were excluded in a listwise fashion.
To avoid collinearity of independent variables related to different measures of sexual risk
behaviour in our logistic regression models, we created a new variable comprising four groups
as shown in Table 1. In doing so, we aimed to approximate roughly the indications for PrEP
use recommended by the CDC for MSM. We chose “two or more partners” rather than “one”
as our cut-off point to account for the possibility that participants who reported condomless
Table 1. Definitions of sexual risk behaviour groups, according to self-reported number of condomless anal inter-
course partners and diagnosis of any sexually transmitted infection over the past six months.
Label for sexual risk
behaviour
Definitions (referring to the past six months)
“Highest risk (CAI + STI)” Reported having had CAI with two or more partners and a diagnosis of any STI
“Higher risk (CAI)” Reported having had CAI with two or more partners but no STI diagnosis
“Higher risk (STI)” Reported having had a diagnosis of any STI but not CAI with two or more
partners
“Low risk” Did not report having had an STI diagnosis or CAI with two or more partners
CAI, condomless anal intercourse; STI, sexually transmitted infection.
https://doi.org/10.1371/journal.pone.0204067.t001
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anal intercourse (CAI) with one partner might be describing CAI within a monogamous part-
nership. We did not distinguish between receptive or insertive CAI because the CDC indica-
tions for PrEP use for MSM do not do so either.
IBM SPSS Version 22 was used for the descriptive statistics and cross-tabulations, whereas
Stata SE 14.2 (StataCorp) was used to estimate the regression models.
Results
All of the HIV and STI testing and counselling centres in Berlin (n = 4) chose to participate in
the study. Of the 11 HIV specialist practices invited to participate, a total of six elected to take
part. The participating centres handed out 875 questionnaires, of which 473 were returned,
yielding a response rate of 54.1%. We excluded three participants because they had indicated
in the questionnaire that they were living with HIV. This left 470 questionnaires for further
analysis.
Demographic data
Of the 470 questionnaires in our analysis sample, 84.9% were in German. The mean age of the
participants was 37.4 years (SD: 11.9; range: 18–79 years), and 94.0% indicated that they lived
in Berlin. Around two-thirds (65.3%) of the participants had a university degree, and 87.4%
described their financial situation as having “enough money” or “more than enough money”
to pay for the things they need. One third of the participants reported either that one or two of
their parents (14.9%) or that they themselves (23.8%) had been born outside Germany. One
quarter of the participants (24.9%) stated that they had no friends or acquaintances living with
HIV, whereas 35.5% and 49.6% reported having acquaintances or friends living with HIV,
respectively.
Sexual risk behaviour
Referring to the past six months, 17.4% of the participants stated that they had been diagnosed
with an STI, 68.1% that they had had anal sex with two or more partners, and 32.1% that they
had had anal sex with two or more partners without using a condom, respectively. According
to our sexual risk behaviour stratification, 58.9% were categorized as “low risk”, 6.4% as
“higher risk (STI)”‘, 22.1% as “higher risk (CAI)”, and 11.1% as “highest risk (CAI + STI)”.
Seven participants could not be assigned to a category due to missing information for either
the number of CAI partners or the diagnosis of an STI in the past six months. Among partici-
pants who reported never having used PrEP, almost one quarter (90/379) indicated that they
had had CAI with two or more partners in the past six months.
When asked whether the sex they have is always as safe as they would like it to be, 66.0% of
all participants agreed or strongly agreed with the statement and 18.9% disagreed or strongly
disagreed. Table 2 gives an overview of the demographic and sexual risk behaviour data.
Awareness of PrEP and sources of information
In total, 90% of participants (n = 423) reported already being aware of PrEP. Of these, 48.2%
agreed or strongly agreed with the statement that they were well informed about PrEP, whereas
31.9% disagreed or strongly disagreed. Their sources of knowledge about PrEP (multiple
answers allowed) were friends or acquaintances (61.7%), magazines, journals or blogs (57.4%),
dating apps or platforms (34.0%), doctors (22.7%), counselling centres (13.9%), and others
(10.6%). Doctors were named as a source of information about PrEP significantly more often
by participants in the “highest risk (CAI + STI)” sexual risk behaviour category than by other
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Table 2. Demographic data and sexual risk behaviour; total sample and subsamples according to type of centre.




N 470 221 249
Age
Mean (SD) 37.4 (11.9) 32.9 (8.0) 41.4 (13.2)
Min; Max 18–79 18–59 19–79
Highest degree or level of school (N, %)
Primary education 0 0 0
Secondary education up to year 10 42 (8.9%) 8 (3.6%) 34 (13.7%)
Secondary education with apprenticeship 23 (4.9%) 5 (2.3%) 18 (7.2%)
Secondary education up to year 12 89 (18.9%) 44 (19.9%) 45 (18.1%)
University degree 307 (65.3%) 160 (72.4%) 147 (59.0%)
Not stated 9 (1.9%) 4 (1.8%) 5 (2.0%)
Financial situation (N, %)
Not always enough money 51 (10.9%) 23 (10.4%) 28 (11.2%)
Enough money 205 (43.6%) 95 (43.0%) 110 (44.2%)
More than enough money 206 (43.8%) 99 (44.8%) 107 (43.0%)
Not stated 8 (1.7%) 4 (1.9%) 4 (1.6%)
Place of residence (N, %)
Berlin 442 (94.0%) 204 (92.3%) 238 (95.6%)
Other city in Germany 10 (2.1%) 4 (1.8%) 6 (2.4%)
Small town / rural area in Germany 4 (0.9%) 3 (1.4%) 1 (0.4%)
Other country 8 (1.7%) 7 (3.2%) 1 (0.4%)
Not stated 6 (1.3%) 3 (1.4%) 3 (1.2%)
Family origins (N, %)
Participants & both parents born in Germany 281 (59.8%) 112 (50.7%) 169 (67.9%)
One parent born outside Germany 32 (6.8%) 19 (8.6%) 13 (5.2%)
Both parents born outside Germany 38 (8.1%) 25 (11.3%) 13 (5.2%)
Participant born outside Germany 112 (23.8%) 62 (28.1%) 50 (20.1%)
Not stated 7 (1.5%) 3 (1.4%) 4 (1.6%)
Current HIV status (N, %)
HIV negative 406 (86.4%) 171 (77.4%) 235 (94.4%)
Not sure 52 (11.1%) 41 (18.6%) 11 (4.4%)
Not stated 12 (2.6%) 9 (4.1%) 3 (1.2%)
STI diagnosis in the past six months (N, %)
No 381 (81.1%) 183 (82.8%) 198 (79.5%)
Yes 82 (17.4%) 34 (15.4%) 48 (19.3%)
Not stated 7 (1.5%) 4 (1.8%) 3 (1.2%)
Role when having anal sex (N, %)
No anal sex 21 (4.5%) 2 (0.9%) 19 (7.6%)
Bottom only 37 (7.9%) 19 (8.6%) 18 (7.2%)
More bottom than top 91 (19.4%) 48 (21.7%) 43 (17.3%)
Top and bottom (versatile) 141 (30.0%) 66 (29.9%) 75 (30.1%)
More top than bottom 99 (21.1%) 47 (21.3%) 52 (20.9%)
Top only 72 (15.3%) 33 (14.9%) 39 (15.7%)
Not stated 9 (1.9%) 6 (2.7%) 3 (1.2%)
Number of anal sex partners in the past six months (N, %)
(Continued)
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participants (42.3% vs. 18.4%, p<0.001). This was not the case with counselling centres, how-
ever (17.3% vs. 12.1%, p = 0.291).
Barriers to PrEP use
Two-thirds (65.6%) of the survey participants agreed or strongly agreed with the statement that
PrEP is a safe way to prevent infection with HIV. Agreement was significantly more common
among participants who had indicated that they were well informed about PrEP (p<0.001). Par-
ticipants attributed the following risks to the use of PrEP (multiple answers allowed): A higher
risk of getting infected with other STIs (64.3%), mild or temporary side effects (43.6%), severe
or permanent side effects (19.8%), a higher risk of getting infected with HIV (6.2%), and other
risks (5.1%). After we applied a Bonferroni-adjusted alpha-level (p<0.005) to account for multi-
ple comparisons across survey items, however, the only differences between the well-informed
versus not- well-informed groups that remained significant were those for the items “Higher
risk of getting infected with other STIs” and “Not sure” (Table 3).
Among participants without a history of PrEP intake (n = 387), the following were named
as circumstances under which they would consider using PrEP (multiple answers allowed): if
they had fewer worries about side effects (47.3%), if it were cheaper (39.8%), if a doctor pre-
scribed it (31.8%), if they had more information (31.3%), and other circumstances (3.7%).
Desire to use PrEP
Among participants with no history of PrEP use (n = 387), 42.4% agreed or strongly agreed
with the statement that they would like to use PrEP themselves, whereas 34.8% disagreed or
Table 2. (Continued)




None 55 (11.7%) 10 (4.5%) 45 (18.1%)
1 80 (17.0%) 36 (16.3%) 44 (17.7%)
2 to 5 142 (30.2%) 85 (38.5%) 57 (22.9%)
6 to 10 79 (16.8%) 38 (17.2%) 41 (16.5%)
More than 10 99 (21.1%) 45 (20.4%) 54 (21.7%)
Not stated 15 (3.2%) 7 (3.2%) 8 (3.2%)
Number of anal sex partners without using condom in the past six months (N, %)
None 174 (37.0%) 68 (30.8%) 106 (42.6%)
1 134 (28.5%) 79 (35.7%) 55 (22.1%)
2 to 5 109 (23.2%) 50 (22.6%) 59 (23.7%)
6 to 10 23 (4.9%) 10 (4.5%) 13 (5.2%)
More than 10 19 (4.0%) 6 (2.7%) 13 (5.2%)
Not stated 11 (2.3%) 8 (3.6%) 3 (1.2%)
STI, sexually transmitted infection.
1Counselling centres: Fixpunkt e.V., Mann-O-Meter e.V., Berliner AIDS-Hilfe e.V., Pluspunkt / Schwulenberatung Berlin gGmbH (listed in descending order according
to number of returned questionnaires).
2Practices: Gemeinschaftspraxis Dietmar Schranz und Klaus Fischer, Praxis Jessen2 + Kollegen, Praxis Wu¨nsche, A¨rztezentrum Nollendorfplatz, Praxiszentrum
Kaiserdamm, Novopraxis Berlin GbR (listed in descending order according to number of returned questionnaires).
or similar.
for example A levels, high school diploma, German “Abitur”.
https://doi.org/10.1371/journal.pone.0204067.t002
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strongly disagreed. In our univariable logistic regression models, the following variables were
significantly positively associated with the desire to take PrEP: belonging to the “higher risk
(CAI)” or “highest risk (CAI + STI)” categories for sexual risk behaviour; perceived riskiness
of own sexual behaviour; and expressing the need to have a doctor who prescribed PrEP.
Attributing to PrEP a higher risk of getting infected with STIs was significantly negatively asso-
ciated with the desire to take PrEP. In our multivariable model, the following factors were sig-
nificant positive predictors of the desire to take PrEP: belonging to the “higher risk (CAI)” or
the “highest risk (CAI + STI)” category; and having expressed the need to have a doctor who
prescribed PrEP. The one significant negative predictor was having attributed to PrEP a higher
risk of getting infected with other STIs (Table 4). A response tree for the multivariable regres-
sion model for the desire to use PrEP is shown in Fig 1.
History of PrEP use and sources of PrEP
The majority of participants (82.3%) had never used PrEP themselves. Of the 81 (17.2%) who
had, 46.9% reported using it continuously, 13.6% using it on-demand and 39.5% using or hav-
ing used it but not on a regular basis. Asked about the source of their PrEP (multiple answers
allowed), 44.4% of the 81 participants reported obtaining a prescription from their doctor,
35.8% importing it from another country, 18.5% using pills originally prescribed for post-
exposure prophylaxis (PEP), 11.1% using pills from a friend’s HIV medication, and 4.9% using
other ways to obtain the medication. Only 32.1% of participants who had a history of PrEP
intake reported using a private prescription as their only source of PrEP, and 59.3% reported
that they had obtained some or all of their PrEP by means other than a private prescription.
This latter number rises to 64.8% if we exclude those who did not answer this question (n = 7).
In our univariable logistic regression models, the following variables were significantly pos-
itively associated with a history of PrEP use: having a university degree, having been born out-
side of Germany, belonging to the “higher risk (CAI)” or the “highest risk (CAI + STI)”
category, having friends or acquaintances living with HIV, and attributing to PrEP a higher
risk of infection with other STIs. In our multivariable analysis, belonging to the “higher risk
(CAI)” or “highest risk (CAI + STI)” sexual risk behaviour category was a strong positive pre-
dictor of having a history of PrEP use. Further positive predictors were having a university
Table 3. Participants’ perception of risks of PrEP use, by self-reported level of knowledge about PrEP.
What risks do you see for people who use PrEP? (multiple answers allowed)
“I am well informed about PrEP” p value§
Agree or strongly agree
(N = 210)
Disagree or strongly disagree
(N = 166)
None 10 (4.8%) 2 (1.2%) 0.051
Mild / temporary side effects 106 (50.5%) 64 (38.6%) 0.021
Severe / permanent side effects 40 (19.0%) 36 (21.7%) 0.527
Higher risk of getting infected with
HIV
8 (3.8%) 14 (8.4%) 0.058
Higher risk of getting infected with
other STIs
156 (74.3%) 96 (57.8%) 0.001
Other risks 14 (6.7%) 4 (2.4%) 0.055
Not sure 7 (3.3%) 41 (24.7%) < .001
STI, sexually transmitted infection.
§From Chi-squared tests of the null hypothesis that there is a no significant difference between the expected
frequencies and the observed frequencies in the categories.
https://doi.org/10.1371/journal.pone.0204067.t003
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degree, one or two parents born outside of Germany, and friends or acquaintances living with
HIV, as well as attributing to PrEP a higher risk of infection with other STIs (Table 5). A
response tree for the multivariable regression model for history of PrEP use is shown in Fig 2.
Anticipated impact of PrEP on participants’ use of condoms
When asked about the extent to which they agreed with the statement that they had (or would
have) anal sex without a condom more often when taking PrEP, 45.4% of the participants
agreed or strongly agreed whereas 33.0% disagreed or strongly disagreed. Participants who
expressed a desire to use PrEP and those who stated that they were using or had used PrEP
were significantly more likely to agree with the statement than other participants (Table 6).
Table 4. ORs and 95% CIs for expressing a desire to use PrEP, by sexual risk behaviour, perceived riskiness of own sexual behaviour, and barriers and risks attrib-
uted to PrEP intake.
Participants
expressing a desire to
use PrEP
Crude OR Adjusted OR†
Participant characteristics N‡ n (%) p value§ (95% CI) (95% CI)
Sexual risk behaviour (past six months) <0.001
No STI; no multiple CAI partners 193 86 (44.6%) Reference Reference
STI; no multiple CAI partners 17 7 (41.2%) 0.85 (0.31–2.33) 1.02 (0.34–3.05)
No STI; multiple CAI partners 66 52 (78.8%) 4.58 (2.33–9.00) 3.77 (1.84–7.69)
STI; multiple CAI partners 20 19 (95.0%) 23.07 (3.03–175.93) 17.22 (2.18–136.14)
Perceived riskiness of own sexual behaviour: “When I have sex, it is always as safe as I’d
like it to be”
<0.001
Strongly disagree 9 6 (66.7%) Reference Reference
Disagree 51 39 (76.5%) 1.27 (0.22–7.39) 2.16 (0.4–11.64)
Neither agree nor disagree 37 27 (73.0%) 1.16 (0.19–7.04) 2.63 (0.46–14.94)
Agree 123 64 (52.0%) 0.44 (0.08–2.37) 1.31 (0.26–6.44)
Strongly agree 73 27 (37.0%) 0.23 (0.04–1.28) 0.77 (0.15–3.90)
“If a doctor prescribed it” 0.012
Not selected as a circumstance under which participant would use PrEP 202 99 (49.0%) Reference Reference
Selected as a circumstance under which participant would use PrEP 97 65 (67.0%) 1.96 (1.17–3.28) 2.44 (1.36–4.37)
“A higher risk of getting infected with HIV” 0.078
Not selected as risk seen for people using PrEP 282 158 (56.0%) Reference Reference
Selected as risk seen for people using PrEP 16 5 (31.3%) 0.38 (0.13–1.14) 0.34 (0.10–1.11)
“A higher risk of getting infected with other STIs” 0.053
Not selected as risk seen for people using PrEP 120 76 (63.3%) Reference Reference
Selected as risk seen for people using PrEP 178 87 (48.9%) 0.53 (0.32–0.87) 0.54 (0.31–0.92)
CAI, condomless anal intercourse; CI, confidence interval; OR, odds ratio; PrEP, HIV pre-exposure prophylaxis; STI, sexually transmitted infection. P-values from joint
Wald tests of the null hypothesis that there is no variation across a category for the univariate and multivariate regression models were <0.0001 and 0.0002 for sexual
risk behaviour, <0.0001 and 0.0576 for perceived riskiness of own sexual behaviour, 0.0095 and 0.0028 for doctor prescription as a pre-condition for PrEP use, 0.074
and 0.0748 for attributing to PrEP a higher risk of getting infected with HIV, and 0.0105 and 0.0243 for attributing to PrEP a higher risk of getting infected with other
STIs, respectively.
†Multivariable analysis adjusting for sexual risk behaviour, perceived riskiness of own sexual behaviour, having a doctor who prescribes PrEP, and risk of HIV and STI
attributed to PrEP intake.
‡The sample excludes patients who were missing information on the relevant variables. Fig 1 gives an overview of participants included and excluded in the regression
model.
§From Chi-squared tests of the null hypothesis that there is a no significant difference between the expected frequencies and the observed frequencies in one or more
categories (e.g., across sexual risk behaviour groups).
"multiple" was defined as reporting having had two or more CAI partners in the past six months.
https://doi.org/10.1371/journal.pone.0204067.t004
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Fig 1. Response tree for the multivariable regression model of desire to use PrEP.
https://doi.org/10.1371/journal.pone.0204067.g001
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Attitudes towards insurance coverage and pricing of PrEP
The majority of participants stated that the cost of PrEP should be covered by public health
insurance in Germany, either for all MSM who want to use PrEP (64.7%) or only for MSM at
the highest risk of acquiring HIV (13.4%). For the majority of participants (59.1%), an accept-
able price per month if PrEP were never to be covered by public health insurance was 50 euros
or less, followed by 100 euros or less for 21.3%, and 200 euros or less for 6.2%.
Discussion
Our study is the first to use a facility-based survey to investigate what MSM in Berlin know
about PrEP, the extent to which and how they use it, and the attitudes they have towards it.
Table 5. ORs and 95% CIs for having a history of PrEP use, by education, family origins, sexual risk behaviour,





Crude OR Adjusted OR†
Participant characteristics N‡ n (%) p value§ (95% CI) (95% CI)
Education 0.014
No university degree 154 16 (10.4%) Reference Reference
University degree 305 61 (20.0%) 2.21 (1.21–-4.04) 2.44 (1.22–4.91)
Family origins 0.031
Participant and parents born in Germany 279 37 (13.3%) Reference Reference
One or two parents born outside Germany 70 17 (24.3%) 1.92 (0.98–3.78) 3.03 (1.37–6.73)
Participant born outside Germany 112 24 (21.4%) 1.82 (1.02–3.24) 1.80 (0.90–3.60)
Sexual risk behaviour (past six months) <0.001
No STI; no multiple CAI partners 276 18 (6.5%) Reference Reference
STI; no multiple CAI partners 30 0 (0.0%) Empty Empty
No STI; multiple CAI partners 103 31 (30.1%) 6.92 (3.57–13.43) 7.25 (3.64–14.45)
STI; multiple CAI partners 52 29 (55.8%) 19.10 (9.04–40.35) 16.18 (7.37–35.53)
Having friends or acquaintances living with HIV <0.001
No 116 5 (4.3%) Reference Reference
Yes 344 73 (21.2%) 5.66 (2.22–14.41) 4.16 (1.53–11.37)
“A higher risk of getting infected with STIs” 0.013
Not selected as risk seen for people using PrEP 165 17 (10.3%) Reference Reference
Selected as risk seen for people using PrEP 302 64 (21.2%) 2.35 (1.28–4.30) 2.77 (1.39–5.52)
CAI, condomless anal intercourse; CI, confidence interval; OR, Odds ratio; PrEP, pre-exposure prophylaxis; STI,
sexually transmitted infection. P-values from joint Wald tests of the null hypothesis that there is no variation across a
category for the univariate regressions and the multivariate regression model were 0.0068 and 0.0120 for education,
0.0537 and 0.0170 for family origins, < .0001 and < .0001 for sexual risk behaviour, <0.0001 and 0.0054 for having
friends or acquaintances living with HIV, and 0.0034 and 0.0039 for attributing PrEP a higher risk of getting infected
with STIs, respectively.
†Multivariable analysis adjusting for education, family origins, sexual risk behaviour, having friends or acquaintances
living with HIV, and risk of STI attributed to PrEP intake.
‡The sample excludes patients who were missing information on the relevant variables. Fig 2 gives an overview of
participants included and excluded in the regression model.
§From Chi-squared tests of the null hypothesis that there is a no significant difference between the expected
frequencies and the observed frequencies in one or more categories (e.g., across sexual risk behaviour groups).
"multiple" was defined as reporting having had two or more CAI partners in the past six months.
https://doi.org/10.1371/journal.pone.0204067.t005
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Fig 2. Response tree for the multivariable regression model for history of PrEP use.
https://doi.org/10.1371/journal.pone.0204067.g002
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We additionally sought to identify factors associated with participants’ willingness to use PrEP
and any history of PrEP use.
With data provided by almost 500 MSM in Berlin with a self-reported negative or unknown
HIV serostatus, we found that awareness of PrEP, at 90%, was very high. However, fewer than
half of those who were aware of PrEP felt well informed about it. This is troubling given that at
least 60% of participants who were currently on PrEP or had used it at some point in the past
reported that they had obtained some or all of their medication from an informal source, such
as imports, pills originally prescribed for PEP or a friend’s HIV medication. The individual
and public health risks of informal PrEP use are manifold and include delays in identifying
side effects and infections with other STIs, an increased risk of HIV infection, and the develop-
ment of drug resistant HIV strains that can be transmitted to others and harder to treat. To
address this situation it will be crucial for policy makers in Germany to consider recent calls
from the German STI Association (DSTIG) and the DAIG to improve access to PrEP and
PrEP education through regular health care services [40,41]. As of July 2018, public health
insurance in Germany did not cover the cost of PrEP medication or any related diagnostic
tests or patient education specifically related to PrEP.
The importance of being able to obtain PrEP through formal channels is further supported
by another of our findings, namely that participants who reported that they were taking PrEP
in a manner consistent with the evidence (i.e., regularly or on-demand) were significantly
more likely to have obtained a prescription from their doctor. Indeed, reliable information on
PrEP would appear to be an important enabler of its proper use considering that participants
who felt they were well informed about PrEP were better at identifying the true risks associated
with it. More generally, the likelihood of having a history of PrEP use was associated in our
regression model with having a university degree and with having friends or acquaintances
who are living with HIV. Information may play a role as an enabler in both scenarios if we
assume that MSM who have a university degree may have better access to health information
or seek it out more assertively than those who do not. Likewise, it is possible that being part of
a social network in which people communicate more openly about HIV leads to greater aware-
ness of the disease and facilitates access to information about HIV medication and prevention.
Conversely, a lack of information was cited as a barrier to PrEP use by almost one third of
participants who had no history of PrEP intake. Given that almost half of this group also indi-
cated that they would consider using PrEP if they had fewer worries about side effects, it
would seem that efforts to improve PrEP education in Germany should focus on the potential
side effects of PrEP therapy in addition to emphasising the importance of adherence and regu-
lar diagnostic testing.
Table 6. Anticipated impact of taking PrEP on participants’ use of condoms, by desire to use PrEP and history of PrEP use.
“I have (or would have) anal sex without a condom more often when taking PrEP”
“I would like to use PrEP myself” p value§ History of PrEP use p value§
Agree or strongly agree (N = 207) Neutral, disagree or strongly disagree (N = 211) Yes (N = 80) No (N = 372)
Strongly disagree 18 (8.7%) 58 (27.5%) < .001 7 (8.8%) 77 (20.7%) 0.002
Disagree 36 (17.4%) 32 (15.2%) 7 (8.8%) 64 (17.2%)
Neither agree nor disagree 23 (11.1%) 38 (18.0%) 8 (10.0%) 55 (14.8%)
Agree 79 (38.2%) 64 (30.3%) 37 (46.3%) 116 (31.2%)
Strongly agree 39 (18.8%) 13 (6.2%) 17 (21.3%) 42 (11.3%)
I never use condoms
anyway
12 (5.8%) 6 (2.8%) 4 (5.0%) 18 (4.8%)
§From Chi-squared tests of the null hypothesis that there is a no significant difference between the expected frequencies and the observed frequencies in the categories.
https://doi.org/10.1371/journal.pone.0204067.t006
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The most frequent sources of information about PrEP for our participants were their
friends and acquaintances, as well as magazines, blogs and dating apps. This is unsurprising
given evidence pointing to the important role of word-of-mouth communication when people
make health-related decisions [42]. Given the high proportion of informal PrEP use suggested
by our data, however, the fact that only a quarter of MSM in our sample reported doctors as
one of their sources of information about PrEP is concerning. One explanation may be that
doctors in Berlin are targeting information at the individuals they feel will benefit the most
from PrEP. This is supported by our finding that those at the highest risk of HIV infection
were significantly more likely to name their doctor as a source of information about PrEP than
those at low risk.
Targeting information to a small group of MSM might also be a way for doctors in Berlin
(and Germany as a whole) to cope with a system of payment for office-based health profession-
als that often makes it difficult to recover the cost of consultations as lengthy as those needed
to educate patients about preventive measures such as PrEP [43,44]. However, one of the goals
of PrEP provision is to avoid informal use of the medications. Our study provides some evi-
dence that this targeting, if it is taking place, may be too narrow, leading to unintended nega-
tive consequences for individual and public health as detailed above. These concerns are
further underscored by our finding that almost one quarter of participants who had no history
of PrEP use reported that they had had condomless anal intercourse with more than one part-
ner over the past six months.
The cost of PrEP is described frequently in the literature as a barrier to its use [45–47]. We
therefore included a question in our survey to identify whether cost might be seen as a barrier
by participants in our sample. However, because the price of a month’s supply of generic PrEP
in Germany fell from approximately 600 euros to as low as 50 euros during the study period,
our data on this question are of limited validity. Regardless, the majority of participants indi-
cated that 50 euros per month was an acceptable price if PrEP continued not to be covered by
public health insurance. Interestingly, most participants also felt that PrEP should be covered
by public health insurance for all MSM who wanted to use it, regardless of their HIV risk. This
suggests that participants may see access to PrEP as a matter of equality in contrast to what
may be a narrowly targeted approach among doctors, as discussed above. In fact, almost one
third of participants with no history of PrEP use indicated that they would consider using
PrEP if a doctor prescribed it for them.
In addition to being more likely to receive information about PrEP from their doctors, par-
ticipants at higher risk of HIV infection because of multiple CAI partners, or because of multi-
ple CAI partners and an STI diagnosis, were much more likely to express the desire to take
PrEP or to have a history of PrEP use than MSM at low risk. This is encouraging, both from an
individual and public health perspective, yet it again raises the issue of informal PrEP use.
Almost half of our participants stated that they had, or would have, anal sex without a condom
more often when taking PrEP, thus increasing their risk of infection with other STIs. More-
over, those who expressed a desire to take PrEP or had a history of PrEP use were significantly
more likely than those who did not to report that they did or would engage in CAI. While STIs
can be detected and treated early among PrEP users who are well integrated into a regular STI
testing scheme, this is rather unlikely for people who obtain PrEP through informal channels
or take it irregularly.
We found evidence that MSM with family but not personal origins outside Germany were
significantly more likely to have a history of PrEP use than MSM with family origins within
Germany. Unfortunately, participants rarely specified which countries their non-German-
born parent or parents came from. We therefore cannot draw any conclusions about whether
this subgroup is representative of MSM whose families come from the historical source
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countries of migration to Berlin, such as Turkey, Poland and Russia [48]. Further studies are
necessary to assess whether the needs of ethnic minorities in Berlin and Germany as a whole
are being adequately met. The same applies to MSM in lower income groups, who are probably
underrepresented in our sample. The state government of Berlin is planning to target this spe-
cific group with a model project that should provide free PrEP services to a limited number of
financially deprived MSM [37].
Some of our findings are similar to those of an anonymous online survey of MSM con-
ducted in Germany in 2016 [49]. The mean age of participants was the same, awareness of
PrEP was similarly common, and similar proportions of participants reported having had an
STI diagnosis within the past six months and being more likely not to use a condom when tak-
ing PrEP. Furthermore, the proportion of patients in our sample who reported obtaining PrEP
only through a private prescription (32.1%) was similar to the proportion of patients in the
sample of Spinner et al. [49] who reported accessing PrEP under medical supervision (29.2%).
Moreover, the proportion of participants in both studies who reported obtaining at least some
of their PrEP through informal channels was similarly high at 60% to 70%.
While sexual risk behaviour was also identified by Spinner et al. as a predictor of having a
history of PrEP use, they defined risk contacts as CAI under the influence of recreational
drugs, whereas we collected data on the frequency of anal intercourse overall and of CAI. Nev-
ertheless, the similarities suggest that both study samples may be broadly representative of the
broader population of MSM in Germany. This being said, the proportion of participants who
reported a history of PrEP use in the survey by Spinner et al. [49] (7.5%) was considerably
lower than in our sample. This in unsurprising, however, if we consider that PrEP uptake in a
city like Berlin with a large population of MSM is likely to be higher than in Germany as a
whole. In a survey of MSM in Amsterdam from 2015,[50] the proportion of participants aware
of PrEP was much lower than that in our study. However, given the rapid developments in the
field of PrEP, such as growing evidence to support its efficacy and safety, efforts to implement
PrEP and reductions in price, this difference between data from 2015 and 2017/18 is similarly
unsurprising.
This study has important limitations. First, when asking participants about their number of
CAI partners, we did not distinguish between insertive and receptive CAI, although the risk of
infection clearly differs between the two. However, we were interested primarily in obtaining
data that could be grouped and analysed according to the CDC recommendations for PrEP
use. Second, like other sampling strategies, facility-based sampling introduces a selection bias
that can limit the external validity of findings [51–53]. While a strength of our sample is its
broad age range (18–79 years), it likely reflects the part of the MSM community in Berlin that
is well integrated within and seeking information from LGBTI counselling centres and HIV-
specialist practices. This may help explain the high proportion of university degrees among
our participants and the low proportion of participants who reported that they or their parents
had been born in the countries with the historically highest flows of migration to Berlin. It is
therefore important to consider that our sample may not include MSM in lower income
groups or who are facing cultural barriers to access and might have the greatest need for infor-
mation and, indeed, PrEP services. Moreover, it is likely that some of the participating doctors
did not, as they had been asked, invite all eligible patients to take part in the survey. This may
have led to patients being more likely to have been included if they asked about PrEP of their
own volition and therefore to selection bias. A third important limitation is that, while we did
not exclude transgender MSM from participating in the survey, we did not explicitly instruct
participating centres to include this group, nor did we measure how many transgender MSM
may have taken part. Other sampling strategies would have been necessary to obtain meaning-
ful data on transgender MSM’s attitudes towards PrEP but would have gone beyond the scope
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of our study. Fourth, although we attempted to recruit several HIV specialist practices in for-
mer East Berlin, only one of these chose to participate. It was very centrally located and may
not cater to many patients on the eastern outskirts of the city, where there are larger numbers
of people with a family history of migration from the former Soviet Union and Vietnam [48].
Obtaining a representative sample of minorities, particularly sexual ones, remains a challenge.
Nevertheless, many of the sociodemographic characteristics in our sample are comparable to
those among participants in earlier, online surveys of MSM in Germany [49,54]. The mean age
of our participants and the proportion of those who reported that they or their parents had
been born outside of Germany were similar to the figures recorded by the participating sexual
health counselling centres in 2016 as part of their routine data collection (mean age: 34.2 years;
52.2% born themselves or with parents born outside Germany) [55].
Lastly, we could not assess patterns of non-response because we had no information on the
total number of patients or clients who were invited to participate in the survey versus the
number who declined. However, as is the case for all epidemiological research, the size of the
observed associations is important. In our study, the relatively high response rate for this type
of research, the multivariable analysis used and the large size of the observed associations, par-
ticularly for sexual risk behaviour, suggest that our findings are not likely to result from non-
response bias alone.
Our post-estimation regression diagnostics, including tests for multicollinearity and poten-
tially influential observations, as well as sensitivity analyses including all variables of a priori
interest, suggest that the findings of both regression models are robust.
Conclusions
Our facility-based survey of almost 500 HIV-negative MSM in Berlin found a very high level
of awareness of PrEP but also a strong need for more education on its pros, cons and proper
use. From an individual and public health perspective, this need should be regarded as acute
given that almost one quarter of our participants who reported never having used PrEP also
reported having had condomless anal intercourse with more than one partner in the past six
months. Moreover, at least 60% of participants who reported using PrEP had obtained some
or all of it through informal channels, making it less likely that they were always taking their
medication under medical supervision. We also found evidence that doctors in Berlin might
be sensibly targeting the provision of PrEP services at those with the highest risk of HIV infec-
tion, but that this targeting could be too narrow, allowing some people to fall through the gaps.
If the Berlin state government intends to go beyond its commitments as part of the Fast-Track
Cities initiative, policy makers at the state and federal levels will need to consider recent calls
from the German STI Association to improve access to PrEP and PrEP education through reg-
ular health services.
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